Dr. Frederick H. Davidorf, MD

Dr. Davidorf practices at OSU Observation Medicine, LLC in Columbus, Ohio.

Dr. Davidorf's NPI, 1548204555, was assigned on June 16, 2006. Dr. Davidorf graduated from Ohio State College of Medicine in 1965. Dr. Davidorf holds Ohio license 35028216.

Dr. Davidorf's primary practice is OSU Observation Medicine, LLC, at 410 W 10th Ave, Columbus, OH 43210 in Franklin County. The practice phone is (614) 293-8000.

Dr. Davidorf's primary practice is OSU Observation Medicine, LLC in Columbus, Ohio. Dmand AI also links Dr. Davidorf to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Davidorf practices. Vendor and product names are available with a free account.

Retina specialist is Dr. Davidorf's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Davidorf is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Davidorf is licensed in Ohio.

Dmand AI lists age-related macular degeneration, cataract, eyelid inflammation, hereditary corneal conditions, retinal detachment, retinal occlusion, vision problems and vitreous eye degeneration among the conditions Dr. Davidorf treats.

CMS data shows 986 Medicare services from Dr. Davidorf across 8 procedure codes in 2024, for 228 Medicare patients. Medicare paid $28,974 for them. Every service was in an office.

CMS counts 228 Medicare patients who saw Dr. Davidorf in 2024. The largest group is 75 to 84, with 90 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Davidorf's median patient age at 76, with 55% women.

In 2024, Dr. Davidorf wrote 72 Medicare Part D claims for 33 patients. 79% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $1,251 in total drug cost. In 2023, CMS named 46 claims across 3 drugs.

Dmand AI links 100 papers to Dr. Davidorf, published from 2004 to 2021. 2011 was the busiest year, with 6. The most frequent topics are Melanoma, Uveal Neoplasms and Choroid Neoplasms. Dr. Davidorf has published most often in Arch Ophthalmol. Dr. Davidorf's most frequent co-authors are Colleen M. Cebulla, MD, Mohamed Helmy Abdel-Rahman, MBBCH, PhD and Karan Rai, MD.

Dmand AI links Dr. Davidorf to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Eye Neoplasms, Vitreous Hemorrhage and Eye Diseases.

CMS Open Payments shows 4 general payments to Dr. Davidorf from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 94% of the total. Carl Zeiss Meditec, Inc. paid the most, $357.

Dmand AI lists 2 awards for Dr. Davidorf, most recently CMS Stage 1 EHR in 2013.

Dr. Davidorf graduated from Ohio State College of Medicine in 1965. Dr. Davidorf is a member of AAO.

Dr. Davidorf is in network with 2 carriers, including Medical Mutual of Ohio and CareSource. HMO plans come from the most carriers, 1. Check the plan with the practice before a visit.